Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy

NCT06899529 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Proliferative Diabetic Retinopathy - High Risk

Interventions

PROCEDURE: Bevacizumab

Sponsor

Christian Ophthalmic Surgery Expedition Network